Table 1 Comparison of patient demographics and baseline characteristics between group A and group B and between group C and group D
| Â | Liver failure | Liver cirrhosis | ||||
|---|---|---|---|---|---|---|
Group A (Age < 45) | Group B (Age ≥ 45) | P value | Group C (Age < 45) | Group D (Age ≥ 45) | P value | |
Sex (M/F) | 33/4 | 23/4 | 0.712 | 25/2 | 24/8 | 0.092 |
Age (years) | 35 (31.5 to 40) | 49 (46 to 61) | 0.000 | 36 (33 to 40) | 53.5 (50.2 to 65) | 0.000 |
ALT (U/L) | 110 (51 to 233.5) | 71 (42 to 395) | 0.430 | 66 (33 to 225) | 38.5 (18.5to 52.8) | 0.001 |
AST(U/L) | 104 (73.5 to 155.5) | 96 (59 to 161) | 0.321 | 81 (66 to 122) | 55.5 (32.5 to 82.5) | 0.002 |
TBIL (mmol/L) | 419.3 ± 167.0 | 379.9 ± 182.5 | 0.369 | 334 (158 to 487) | 120.5 (53.8 to 444.5) | 0.024 |
PTA | 34 (27 to 42) | 35 (28 to 43) | 0.600 | 42 (34 to 48) | 43 (34 to 59) | 0.645 |
MELD | 27 (25 to 30) | 27 (25 to 30) | 0.881 | 25 (21 to 26) | 22 (17 to 26) | 0.155 |
AFP | 105.7 (36.5 to 219.7) | 70.5 (7.5 to 200.6) | 0.229 | 85.0 (8.1 to 290.0) | 7.8 (1.9 to 38.0) | 0.002 |